These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 15848904)
1. Gene expression in midgut carcinoid tumors: potential targets for immunotherapy. Vikman S; Essand M; Cunningham JL; de la Torre M; Oberg K; Tötterman TH; Giandomenico V Acta Oncol; 2005; 44(1):32-40. PubMed ID: 15848904 [TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors. Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934 [TBL] [Abstract][Full Text] [Related]
4. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations. Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367 [TBL] [Abstract][Full Text] [Related]
6. Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma. Dasgupta S; Tripathi PK; Qin H; Bhattacharya-Chatterjee M; Valentino J; Chatterjee SK Oral Oncol; 2006 Mar; 42(3):306-16. PubMed ID: 16321566 [TBL] [Abstract][Full Text] [Related]
7. A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy. Leja J; Dzojic H; Gustafson E; Oberg K; Giandomenico V; Essand M Clin Cancer Res; 2007 Apr; 13(8):2455-62. PubMed ID: 17438105 [TBL] [Abstract][Full Text] [Related]
8. Expression of tyrosine kinase receptors in malignant midgut carcinoid tumors. Welin S; Fjällskog ML; Saras J; Eriksson B; Janson ET Neuroendocrinology; 2006; 84(1):42-8. PubMed ID: 17047316 [TBL] [Abstract][Full Text] [Related]
9. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors. Modlin IM; Gustafsson BI; Drozdov I; Nadler B; Pfragner R; Kidd M Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963 [TBL] [Abstract][Full Text] [Related]
10. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker. Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N Urol J; 2009; 6(2):101-8. PubMed ID: 19472128 [TBL] [Abstract][Full Text] [Related]
11. First report on metastasizing small bowel carcinoids in first-degree relatives in three generations. Järhult J; Landerholm K; Falkmer S; Nordenskjöld M; Sundler F; Wierup N Neuroendocrinology; 2010; 91(4):318-23. PubMed ID: 20460879 [TBL] [Abstract][Full Text] [Related]
12. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065 [TBL] [Abstract][Full Text] [Related]
13. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224 [TBL] [Abstract][Full Text] [Related]
14. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer. Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215 [TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of three novel cell lines - P-STS, L-STS, H-STS - derived from a human metastatic midgut carcinoid. Pfragner R; Behmel A; Höger H; Beham A; Ingolic E; Stelzer I; Svejda B; Moser VA; Obenauf AC; Siegl V; Haas O; Niederle B Anticancer Res; 2009 Jun; 29(6):1951-61. PubMed ID: 19528452 [TBL] [Abstract][Full Text] [Related]
16. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284 [TBL] [Abstract][Full Text] [Related]
17. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival. Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer. Warnecke-Eberz U; Hokita S; Xi H; Higashi H; Baldus SE; Metzger R; Brabender J; Bollschweiler E; Mueller RP; Dienes HP; Hoelscher AH; Schneider PM Oncol Rep; 2005 Jun; 13(6):1241-6. PubMed ID: 15870949 [TBL] [Abstract][Full Text] [Related]
19. Identification of a novel prostate cancer-associated tumor antigen. Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878 [TBL] [Abstract][Full Text] [Related]
20. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Aung PP; Oue N; Mitani Y; Nakayama H; Yoshida K; Noguchi T; Bosserhoff AK; Yasui W Oncogene; 2006 Apr; 25(17):2546-57. PubMed ID: 16331256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]